Clinical Trial Update: A Study of Bevacizumab With Carboplatin and Paclitaxel Chemotherapy for the First-Line Treatment of Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab plus carboplatin and paclitaxel as first-line therapy for metastatic melanoma; the study is completed and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Genentech, Inc. | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2011-09-28